Publications des 5 dernières années

Vous trouverez ici la liste des publications de l'équipe sur les 5 dernières années, pour avoir l'ensemble des données vous pouvez consulter la page des productions.

Articles à comité de lecture (rang A)

  1. Champiré, A. ; Berabez, R. ; Braka, A. ; Cosson, A. ; Corret, J. ; Girardin, C. ; Serrano, A. ; Aci-Sèche, S. ; Bonnet, P. ; Josselin, B. ; Brindeau, P. ; Ruchaud, S. ; Leguevel, R. ; Chatterjee, P. ; Mathea, S. ; Knapp, S. ; Brion, R. ; Verrecchia, F. ; Vallée, B. ; Plé, K. ; Routier, S.
    Tetrahydropyridine LIMK inhibitors: Structure activity studies and biological characterization
    Eur. J. Med. Chem. 2024, 271, 116391.
    Impact Factor: 6.7 - Quartile : 1

  2. Michel, M. ; Caré, F. ; Bourg, S. ; Bostyn, S. ; Lafite, P. ; Routier, S. ; Buron, F.
    Access to mono-, di- and tri-(het)arylated pyrazolo[5,1-b]oxazoles using cyclization, C−H activation and Suzuki–Miyaura palladium-catalyzed reactions
    Eur. J. Org. Chem. 2024, 27, e202301040.
    Impact Factor: 2.8 - Quartile : 1

  3. Moreau, C. ; Lukačević, T. ; Pallier, A. ; Sobilo, J. ; Aci-Sèche, S. ; Garnier, N. ; Même, S. ; Tóth, E. ; Lacerda, S.
    Peptide-conjugated MRI probe targeted to netrin-1, a novel metastatic breast cancer biomarker
    Bioconjugate Chem. 2024, 35, 265–275.
    Impact Factor: 4.7

  4. Yaacoub, K. ; Pedeux, R. ; Lafite, P. ; Jarry, U. ; Aci-Sèche, S. ; Bonnet, P. ; Daniellou, R. ; Guillaudeux, T.
    The identification of new c-FLIP inhibitors for restoring apoptosis in TRAIL-resistant cancer cells
    Curr. Issues Mol. Biol. 2024, 46, 710-728.
    Impact Factor: 3.1 - Quartile : 2

  5. Aci-Sèche, S. ; Bourg, S. ; Bonnet, P. ; Rebehmed, J. ; de Breven, A. G. ; Diharce, J.
    A perspective on the sharing of docking data
    Data in Brief 2023, 109386.
    Impact Factor: 1.2 - Quartile : 2

  6. Arora, R. ; Linders, J. T. M. ; Aci-Sèche, S. ; Verheyen, T. ; Van Heerde, E. ; Brehmer, D. ; Chaikuad, A. ; Knapp, S. ; Bonnet, P.
    Design, synthesis and characterisation of a novel type II B-RAF paradox breaker inhibitor
    Eur. J. Med. Chem. 2023, 115231.
    Impact Factor: 6.7 - Quartile : 1

  7. Libouban, P.-Y. ; Aci-Sèche, S. ; Gómez-Tamayo, J. C. ; Tresadern, G. ; Bonnet, P.
    The impact of data on structure-based binding affinity predictions using deep neural networks
    Int. J. Mol. Sci. 2023, 24, 16120.
    Impact Factor: 5.6 - Quartile : 1

  8. Avula, S. ; Peng, X. ; Lang, X. ; Tortorella, M. ; Josselin, B. ; Bach, S. ; Bourg, S. ; Bonnet, P. ; Buron, F. ; Ruchaud, S. ; Routier, S. ; Néagoie, C.
    Design and biological evaluation of substituted 5,7-dihydro-6H-indolo[2,3-c]quinolin-6-one as novel selective Haspin inhibitors
    J. Enzym. Inhib. Med. Chem. 2022, 37, 1632-1650.
    Impact Factor: 5.6

  9. Miret-Casals, L. ; Van De Putte, S. ; Aerssens, D. ; Diharce, J. ; Bonnet, P. ; Madder, A.
    Equipping coiled-coil peptide dimers with furan warheads reveals novel cross-link partners
    Frontiers in Chemistry 2022, 9, 799706.
    Impact Factor: 5.5

  10. Ziada, S. ; Diharce, J. ; Raimbaud, E. ; Aci-Sèche, S. ; Ducrot, P. ; Bonnet, P.
    Estimation of drug-target residence time by targeted molecular dynamics simulations
    Journal of Chemical Information and Modelin 2022, 62, 5536-5549.
    Impact Factor: 5.6

  11. Buron, F. ; Rodrigues, N. ; Saurat, T. ; Hiebel, M.-A. ; Bourg, S. ; Bonnet, P. ; Nehmé, R. ; Morin, Ph. ; Percina, N. ; Corret, J. ; Vallée, B. ; Le Guével, R. ; Jourdan, M.-L. ; Bénédetti, H. ; Routier, S.
    Design, Synthesis and SAR in 2,4,7-Trisubstituted Pyrido[3.2-d]Pyrimidine Series as Novel PI3K/mTOR Inhibitors
    Molecules 2021, 26, 5349.
    Impact Factor: 4.927

  12. Faarasse, S. ; El Kazzouli, S. ; Bourzikat, O. ; Bourg, S. ; Aci-Sèche, S. ; Bonnet, P. ; Suzenet, F. ; Guillaumet, G.
    Palladium-Catalyzed Regioselective C−H Arylation of 4-Azaindazole at C3, C5 and C7 Positions
    Adv. Synth. Catal. 2021, 363, 3937-3945.
    Impact Factor: 5.981

  13. Bosc, N. ; Muller, C. ; Hoffer, L. ; Lagorce, D. ; Bourg, S. ; Derviaux, C. ; Gourdel, M.-E. ; Rain, J.-C. ; Miller, T. W. ; Villoutreix, B. O. ; Miteva, M. A. ; Bonnet, P. ; Morelli, X. ; Sperandio, O. ; Roche, P.
    Fr-PPIChem: An academic compound library dedicated to protein–protein interactions
    ACS Chem. Biol. 2020, 15, 1566–1574.
    Impact Factor: 5.1

  14. Bournez, C. ; Carles, F. ; Peyrat, G. ; Aci-Sèche, S. ; Bourg, S. ; Meyer, C. ; Bonnet, P.
    Comparative assessment of protein kinase inhibitors in public databases and in PKIDB
    Molecules 2020, 25, 3226.
    Impact Factor: 4.412

  15. Braka, A. ; Garnier, N. ; Bonnet, P. ; Aci-Sèche, S.
    Residence time prediction of type 1 and 2 kinase inhibitors from unbinding simulations
    J. Chem. Inf. Model. 2020, 60, 342-348.
    Impact Factor: 4.956

  16. Elie, J. ; Feizbakhsh, O. ; Desban, N. ; Josselin, B. ; Baratte, B. ; Bescond, A. ; Duez, J. ; Fant, X. ; Bach, S. ; Marie, D. ; Place, M. ; Ben Salah, S. ; Chartier, A. ; Berteina-Raboin, S. ; Chaikuad, A. ; Knapp, S. ; Carles, F. ; Bonnet, P. ; Buron, F. ; Routier, S. ; Ruchaud, S.
    Design of new disubstituted imidazo[1,2-b]pyridazine derivatives as selective Haspin inhibitors. Synthesis, binding mode and anticancer biological evaluation
    J. Enzym. Inhib. Med. Chem. 2020, 35, 1840–1853.
    Impact Factor: 5.051

  17. Fogha, J. ; Diharce, J. ; Obled, A. ; Aci-Sèche, S. ; Bonnet, P.
    Computational analysis of crystallization additives for the identification of New allosteric sites
    ACS Omega 2020, 5, 2114-2122.
    Impact Factor: 3.512

  18. Gally, J.-M. ; Bourg, S. ; Fogha, J. ; Do Q.T. ; Aci-Sèche, S. ; Bonnet, P.
    VSPrep: A KNIME workflow for the preparation of molecular databases for virtual screening
    Current Medicinal Chemistry 2020, 27, 6480.
    Impact Factor: 4.53

  19. Ibrahim, N. ; Bonnet, P. ; Brion, J.-D. ; Peyrat, J.-F. ; Brignon, J. ; Levaique, H. ; Josselin, B. ; Robert, T. ; Colas, P. ; Bach, S. ; Messaoudi, S. ; Alami, M. ; Hamze
    Identification of a new series of flavopiridol-like structures as kinase inhibitors with high cytotoxic potency
    Eur. J. Med. Chem. 2020, 199, 112355.
    Impact Factor: 6.514

  20. Raimbault, A. ; Ma, C. M. A. ; Ferri, M. ; Bäurer, S. ; Bonnet, P. ; Bourg, S. ; Lämmerhofer, M. ; West, C.
    Cinchona-based zwitterionic stationary phases: Exploring retention and enantioseparation mechanisms in supercritical fluid chromatography with a fragmentation approach
    J. Chromatogr. A 2020, 1612, 460689.
    Impact Factor: 4.759

  21. Rieux, C. ; Goffinont, S. ; Coste, F. ; Tber, Z. ; Cros, J. ; Roy, V. ; Guérin, M. ; Gaudon, V. ; Bourg, S. ; Biela, A. ; Aucagne, V. ; Agrofoglio, L. A. ; Garnier, N. ; Castaing, B.
    Thiopurine derivative-induced Fpg/Nei DNA glycosylase inhibition: structural, dynamic and functional insights
    Int. J. Mol. Sci. 2020, 21, 2058.
    Impact Factor: 5.924

  22. Diharce, J. ; Cueto, M. ; Beltramo, M. ; Aucagne, V. ; Bonnet, P.
    In silico peptide ligation: iterative residue docking and linking as a new approach to predict protein-peptide interactions
    Molecules 2019, 24, 1351.
    Impact Factor: 3.267

  23. Driowya, M. ; Guillot, R. ; Bonnet, P. ; Guillaumet, G.
    Development of novel and efficient processes for the synthesis of 5-amino and 5-iminoimidazo[1,2-a]imidazoles via three-component reaction catalyzed by zirconium(IV) chloride
    Frontiers in Chemistry 2019, 7, 457-465.
    Impact Factor: 3.693

  24. Duval, J. ; Colas, C. ; Bonnet, P. ; Lesellier, E.
    Hyphenation of ultra-​high performance supercritical fluid chromatography with atmospheric pressure chemical ionisation high resolution mass spectrometry: Part 2. Study of chromatographic and mass spectrometry parameters for the analysis of natural non-​polar compounds
    J. Chromatogr. A 2019, 1596, 199-208.
    Impact Factor: 4.049

  25. Sirbu, D. ; Diharce, J. ; Martinić, I. ; Chopin, N. ; Eliseeva, S. ; Guillaumet, G. ; Petoud, S. ; Bonnet, P. ; Suzenet, F.
    An original class of small sized molecules as versatile fluorescent probes for cellular imaging
    Chem. Commun. 2019, 54, 7776-7779.
    Impact Factor: 5.996

l'impact factor moyen est de : 4.807



Vulgarisation

  1. Aci-Sèche, S. ; Bonnet, P. ; Younès, S.
    Une simulation numérique pour mieux sélectionner les médicaments avant les essais cliniques
    Actualités de l'INC 2020, .